IN2013MU02631A - - Google Patents
Download PDFInfo
- Publication number
- IN2013MU02631A IN2013MU02631A IN2631MU2013A IN2013MU02631A IN 2013MU02631 A IN2013MU02631 A IN 2013MU02631A IN 2631MU2013 A IN2631MU2013 A IN 2631MU2013A IN 2013MU02631 A IN2013MU02631 A IN 2013MU02631A
- Authority
- IN
- India
- Prior art keywords
- preparation
- sugar alcohol
- rate controlling
- pharmaceutical composition
- controlling polymer
- Prior art date
Links
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 abstract 1
- DCCSDBARQIPTGU-HSZRJFAPSA-N fesoterodine Chemical compound C1([C@@H](CCN(C(C)C)C(C)C)C=2C(=CC=C(CO)C=2)OC(=O)C(C)C)=CC=CC=C1 DCCSDBARQIPTGU-HSZRJFAPSA-N 0.000 abstract 1
- 229960002978 fesoterodine Drugs 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- 229940124531 pharmaceutical excipient Drugs 0.000 abstract 1
- 229920000642 polymer Polymers 0.000 abstract 1
- 150000005846 sugar alcohols Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/222—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having aromatic groups, e.g. dipivefrine, ibopamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Emergency Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/IN2014/000523 WO2015022703A1 (fr) | 2013-08-12 | 2014-08-11 | Composition pharmaceutique stable de chlorhydrate de fésotérodine |
| IN2631MU2013 IN2013MU02631A (fr) | 2013-08-12 | 2014-08-11 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN2631MU2013 IN2013MU02631A (fr) | 2013-08-12 | 2014-08-11 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2013MU02631A true IN2013MU02631A (fr) | 2015-06-19 |
Family
ID=52468120
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN2631MU2013 IN2013MU02631A (fr) | 2013-08-12 | 2014-08-11 |
Country Status (2)
| Country | Link |
|---|---|
| IN (1) | IN2013MU02631A (fr) |
| WO (1) | WO2015022703A1 (fr) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TR201721437A2 (tr) * | 2017-12-25 | 2019-07-22 | Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi | Fesoterodi̇ni̇n modi̇fi̇ye salim sağlayan formülasyonlari |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010010464A2 (fr) * | 2008-07-21 | 2010-01-28 | Actavis Group Ptc Ehf | Fésotérodine essentiellement exempte d’impureté dihydroxy |
| EP2198857A1 (fr) * | 2008-12-19 | 2010-06-23 | Ratiopharm GmbH | Comprimé dispersible oral |
| EP2508175A1 (fr) * | 2011-04-08 | 2012-10-10 | LEK Pharmaceuticals d.d. | Composition pharmaceutique contenant de la fésotérodine ou un sel ou un solvate de celle-ci |
| GR1007628B (el) * | 2011-07-27 | 2012-06-29 | Φαρματεν Αβεε, | Φαρμακευτικο σκευασμα περιεχον εναν αντιμουσκαρινικο παραγοντα και μεθοδος για την παρασκευη αυτου |
-
2014
- 2014-08-11 WO PCT/IN2014/000523 patent/WO2015022703A1/fr not_active Ceased
- 2014-08-11 IN IN2631MU2013 patent/IN2013MU02631A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2015022703A1 (fr) | 2015-02-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3315608A4 (fr) | Arnsi, composition pharmaceutique et conjugué contenant un arnsi, et utilisations de ces derniers | |
| IL257937B (en) | A pharmaceutical preparation containing an anionic drug and a preparation method for it | |
| EP3378859A4 (fr) | Dérivé du benzofurane, son procédé de préparation et son utilisation en médecine | |
| EP3272387A4 (fr) | Dispositif d'administration de médicament, et procédé de fabrication de dispositif d'administration de médicament | |
| EP3020407A4 (fr) | Composition de médecine chinoise traditionnelle, procédé de préparation et application associés | |
| EP3020408A4 (fr) | Composition de médecine traditionnelle chinoise, préparation et application de celle-ci | |
| EP3100731A4 (fr) | Conjugué de médicaments cytotoxiques et de ligands, son procédé de préparation et ses applications | |
| HK1218621A1 (zh) | 用於治疗慢性炎症和炎性疾病的组合物及方法 | |
| EP3254667A4 (fr) | Composition photodurcissable, prothèse dentaire et dentier | |
| EP3359193A4 (fr) | Nouveaux anticorps carbohydrate, compositions pharmaceutiques et leurs utilisations | |
| SG10201507607RA (en) | Process For Producing Traditional Chinese Medicine Compositions, And Compositions Obtainable By The Process | |
| EP3067059A4 (fr) | Composition pharmaceutique pour prévenir ou traiter des maladies thyroïdiennes, contenant de l'extrait de fruit de lonicera caerulea l. var. edulis comme principe actif | |
| MX359288B (es) | Forma iv del clorhidrato de ivabradina. | |
| EP3281527A4 (fr) | Composition antimicrobienne à base de médicaments traditionnels chinois, et son procédé de préparation et son utilisation | |
| EP3133071A4 (fr) | Dérivé c-aryl indican et composition pharmaceutique correspondante, procédé de préparation associé et utilisations associées | |
| ZA201509307B (en) | Pharmaceutical composition, preparation and uses thereof | |
| IN2014DN06966A (fr) | ||
| EP3048103A4 (fr) | Composé immunomodulateur, son utilisation et composition pharmaceutique comprenant ce composé | |
| IN2013MU00711A (fr) | ||
| EP3263155A4 (fr) | Dispositif d'administration de solution médicamenteuse | |
| HRP20181274T1 (hr) | Farmaceutska mješavina za pripremu infuzijskih otopina antimikrobnih pripravaka, njezin proizvodni proces | |
| MX2017001487A (es) | Sofosbuvir en forma cristalina y proceso para su preparacion. | |
| EP3020417A4 (fr) | Composition pharmaceutique à administrer par les voies respiratoires | |
| IN2013MU01985A (fr) | ||
| EP3351286A4 (fr) | Dispositif d'administration de solution de médicament |